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D1d-restricted Va14 invariant NKT (iNKT) cells are a conserved lymphocyte lineage that coexpress a TCR as well as several receptors identified on NK cells, such as NK1.1, IL-2/15Rb-chain (CD122), and various Ly49 molecules (1) (2) (3) . iNKT cells are developed from CD4 + CD8 + double-positive (DP) thymus precursors and are characterized by the expression of the homologous invariant Va14-Ja18/Vb8 and Va24-Ja18/Vb11 TCR chains in mice and humans, respectively (4) (5) (6) . Rare DPprecursor cells that express Va14-Ja18 TCR-a chain are first positively selected by CD1d, a nonclassical MHC-I like molecule. iNKT cells then undergo a development and maturation process involving the sequential downregulation of CD24 and upregulation of CD44 and NK1.1 (7) (8) (9) stage, iNKT cells are still considered immature, but can leave the thymus and colonize peripheral organs, where they reside mostly in the liver, spleen, and bone marrow, and are less abundant in the lymph nodes. The final maturation stage, which occurs either in the thymus or in the peripheral organs, is defined by the expression of NK1.1 (stage 3) (8, 10) . In addition to the acquisition of NK1.1 expression, the final maturation of iNKT cells is also accompanied by the upregulation of several other cell surface receptors, including CD122, CD69, Ly49C/I, and Ly49G2 (11, 12) . Mature CD1d-dependent iNKT cells exhibit a memory phenotype (CD62L 2 CD69 + CD44 high ) and can be either CD4 + single-positive or CD4
2 CD8 2 double-negative (DN) cells (13) . The CD1d-restricted glycosphingolipid Ag a-galactosylceramide (aGalCer) potently activates iNKT cells, triggering within hours the copious production of a wide range of Th1 and Th2 cytokines such as IFNg and IL-4 (14) . The early and potent cytokine secretion by Va14 iNKT cells following TCR stimulation provides an important link between the innate and adaptive immune systems. Consistent with this, Va14 iNKT cells appear to play an important role in regulating early immune responses to infections, maintenance of selftolerance, and antitumor functions (15) (16) (17) (18) (19) . The development of iNKT cells is controlled by different transcription factors, cytokines, and signaling molecules involved in the SLAM/Fyn/SAP/protein kinase C and NF-kB signaling pathways. Deleting just one of these molecules impairs iNKT cell generation and/or development, indicating that multiple regulation mechanisms concomitantly control the development of iNKT cells (10, (20) (21) (22) (23) (24) . Small microRNAs (miRNAs) are short noncoding RNAs (20-23 nt) that negatively regulate gene expression by inducing the degradation or translational repression of the target protein-coding mRNAs (25) . Recently, our laboratory and another group found that deletion of Dicer, the RNase III enzyme essential for the processing of mature functional miRNAs, results in a profound interruption of iNKT cell development, maturation, and function (26) (27) (28) . However, little insight has been made concerning the role of specific miRNAs in the development and function of iNKT cells. MiRNA microRNA-150 (miR-150) is selectively expressed in mature B and T cells, but not their progenitors. Deficiency of miR-150 blocks B1 cell expansion and enhances humoral immune response (29, 30) . In this report, we found that the expression of miR-150 was upregulated during iNKT cell maturation and activation. To test the potential role of miR-150 in iNKT cells, we compared iNKT cell development and function between miR-150 knockout (KO) and wild-type (WT) mice. We found that miR-150 deletion impaired iNKT cell final maturation in both thymus and peripheral lymphoid organs, and that iNKT cells from miR-150KO mice showed increased cytokine production capacity. Furthermore, bone marrow transfer experiments indicated that the maturation and functional changes of iNKT cells in miR-150KO mice are intrinsic to iNKT cells. Together, our results define a specific role of miR-150 in the development and function of iNKT cells.
Materials and Methods

Mice
Conventional miR-150KO mice in C57BL/6 background and WT C57BL/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and bred in our animal facility. In this study, 6-to 10-wk-old age and sexmatched miR-150KO and WT mice were used. Handling of mice and experimental procedures were in accordance with requirements of the Institutional Animal Care and Use Committee.
Genotyping
MiR-150KO mice were genotyped using the following PCR primer pairs: 59-CAAGGACAGGAACCCTTCAGCA-39 and 59-CCATGATGCCTGG-AAGACATTTC-39. The miR-150 deletion allele produced a 262-bp PCR product, whereas the wild-type allele resulted in a 866-bp product.
Flow cytometry
Single-cell suspensions were washed twice with staining buffer (PBS, 2% FCS) and incubated with Fc block (clone 2.4G2). Cells were stained with PBS57-CD1d tetramers, as described (31) . The following conjugated mAbs were used: NK1.1 (PK136), TCR-b (H57-597), CD44 (IM7), CD122 (5H4), CD69 (H1.2F3), B220 (RA3-6B2), LY49C (5E6), LY 49G2 (4D11); CD1d (1B1), CD8 (53-6.7), CD4 (RM4-5), CD25 (PC61), Foxp3 (FJK-16s), IL-4 (11B11), and IFN-g (XMG1.2). All mAbs were from BD Biosciences or eBioscience. Data were analyzed using CELLQuest Pro (BD Biosciences) or FlowJo software. Apoptosis assays were carried out by staining with annexin V (BD Biosciences), according to the manufacturer's instructions. For iNKT cell proliferation in vivo, as revealed by incorporation of BrdU, BrdU (BD Biosciences) was injected at 1 mg/ mouse (i.p.). After 24 h of BrdU injection, thymocytes were analyzed using FITC BrdU Flow Kit (BD Biosciences), as per manufacturer's protocol.
In vivo a-GalCer-induced activation assay
Two micrograms of a-GalCer or vehicle in 100 ml PBS was injected into the tail vein. For intracellular cytokine staining, spleen cells were collected at 2 h after injection and cultured in T cell medium (RPMI 1640 with 10% FCS, HEPES, penicillin and streptomycin, pyruvate, nonessential amino acids, L-glutamine, and 2-ME). Golgistop was added to a final concentration of 3 mM, and the cells were incubated for an additional hour. Cells were extracellularly stained with anti-TCRb and CD1d tetramer. After washing and fixing with 2% paraformaldehyde, cells were permeabilized with 0.1% saponin and stained with anti-IFN-g and anti-IL-4 Abs and analyzed by flow cytometry.
In vitro PMA and ionomycin activation assay
Spleen cells from WT and miR-150 KO mice were cultured in T cell medium (RPMI 1640 with 10% FCS, HEPES, penicillin and streptomycin, pyruvate, nonessential amino acids, L-glutamine, and 2-ME) in the presence of PMA (50 ng/ml) and ionomycin (1 mM) for 1 h; Golgistop was added to a final concentration of 3 mM; and the cells were incubated for an additional 2 h. IFN-g and anti-IL-4 were detected by intracellular staining and flow cytometry.
iNKT cell sorting
Total thymocytes and spleen cells from normal C57BL/6 mice were first stained with anti-mouse CD8 biotin (for thymocytes) or anti-mouse CD8 biotin and anti-mouse B220 biotin Abs (for spleen cells), and CD8 + T cells and B220 + cells were then depleted with anti-biotin beads using auto-MACS (Miltenyi Biotec). Negatively selected cells were then stained with TCR-b Ab, a-GalCer/CD1d tetramers, anti-mouse NK1.1, and CD44 Abs. Total or different stages of iNKT cells were then sorted by BD FACS AriaII.
Real-time RT-PCR
RNAs from total thymocytes, spleen T cells, and iNKT cells from miR-150KO or WT control mice were purified, respectively, using the Ambion mirVana miRNA isolation kit (Ambion), according to the manufacturer's instructions. The expression of miR-150 was examined using the Applied Biosystems TaqMan MicroRNA Assay kit (Applied Biosystems, Foster City, CA), according to the manufacturer's instructions; snoRNU202 was used as endogenous control. c-Myb (Mm00501741) and GAPDH TaqMan real-time PCR primers and probes were purchased from Applied Biosystems. PCR amplification was carried out on the Applied Biosystems 7900 Real-Time PCR system; relative quantization using thê CT value in miR-150KO versus WT control mice was carried out; and fold changes were calculated.
Mixed bone marrow transfer experiments
To generate bone marrow chimeras, 6-to 8-wk-old B6.SJL recipient mice (CD45.1 + ) were lethally irradiated initially with 900 rad. Donor bone marrows were harvested from age-and sex-matched B6.SJL and miR-150KO mice (CD45.2 + ) by flushing with a syringe containing sterile basal tissue culture medium. After erythrocyte lysis, mature T cells were depleted by biotin-conjugated anti-mouse CD3 (BD Biosciences) mAbs and anti-biotin magnetic beads (Miltenyi Biotec) from bone marrows from each donor, using an AutoMACS sorter (Miltenyi Biotec). Over 90% of mature T cell depletion was confirmed by flow cytometry. CD45.1 + B6.SJL and CD45.2 + miR-150KO mice bone marrows were mixed at a 1:1 ratio, and 10 million cells per mouse (in a volume of 100 ml) were then injected into the irradiated recipients by tail vein. The chimeras were analyzed 8 wk after reconstitution.
Statistical analysis
Statistical analysis was performed with Prism 5.0 (GraphPad Software). The two-tailed Student t test was used. Differences were considered statistically significant when values of p , 0.05.
Results
Stage-specific expression of miR-150 during iNKT cell development
To detect miR-150 expression during the development of iNKT cell, thymocytes from normal C57BL/6 mice were stained with Abs against TCR-b, PBS57-CD1d tetramer, CD44, and NK1.1; different stages of iNKT cells were sorted based on CD44 and NK1.1 expression (Fig. 1A) . MiR-150 expression was then detected by TaqMan real-time PCR. As shown in Fig. 1B , miR-150 expression was detectable in all three stages of iNKT cells. However, miR-150 expression increased gradually during the maturation of iNKT cells and reached the highest level at the final maturation stage 3 (CD44 + NK1.1 + ), consistent with recent findings by Bezman et al. (32) . INKT cells from spleen have a relatively higher miR-150 expression level compared with thymus iNKT cells, and miR-150 is also highly expressed in conventional thymic and splenic T cells (Supplemental Fig. 1A ). This is consistent with a previous report that miR-150 is highly expressed in mature and resting lymphocytes (29) . Nevertheless, in contrast with the report showing downregulated miR-150 in B cells after activation (29) , in vivo stimulation of iNKT cells with a-GalCer for 3 d resulted in a significantly increased miR-150 expression in spleen iNKT cells (Fig. 1C) . Thus, the stage-specific expression pattern of miR-150 during iNKT cell development and activation suggests its potential involvement in iNKT cell development and function.
Defective iNKT cell development in miR-150KO mice
To assess the role of miR-150 in iNKT cell development, conventional miR-150KO mice were evaluated and compared with age-and sex-matched WT B6 mice. TaqMan real-time PCR analysis confirmed the substantial deletion of miR-150 in the thymus and spleen of miR-150KO mice compared with that of WT control mice (Supplemental Fig. 1B Fig. 2C ). The miR-150KO mice showed a DN thymocyte developmental profile comparable to that of WT control mice, indicating that miR-150 deficiency did not affect conventional T cell development. In addition, we also found no significant changes of CD4 + Foxp3 + regulatory T cell and gd T cell ratios in the thymus of miR-150KO mice compared with that of WT control mice (Supplemental Fig. 2D, 2E ). Interestingly, we found significant reduction of the percentage (p = 0.001) and cell number (p = 0.04) of thymus iNKT cells stained by anti-TCR-b and PBS57-CD1d tetramers in the miR-150KO mice compared with that in WT mice ( Fig. 2A-C) . The iNKT cells from spleen, lymph nodes, bone marrow, and liver were further analyzed. As shown in Fig. 2D-F , the frequencies and number of iNKT cells in the spleen, bone marrow, and liver from miR-150KO mice were comparable with that from WT control mice. However, significantly increased frequency (p = 0.028) and number (p = 0.035) of iNKT cells were observed in the lymph nodes from miR-150KO mice compared with that from WT control mice. Thus, deficiency of miR-150 causes an impairment of development in thymus iNKT cells, but not in conventional T cells, CD4 + Foxp3 + regulatory T cells, and gd T cells.
Defective iNKT cell maturation in miR-150KO mice
Accumulated studies have indicated that iNKT cells undergo a series of maturation stages in the thymus immediately after positive selection, based on their CD44 and NK1.1 expressions. Given that iNKT cells exhibit a stage-specific miR-150 expression pattern, the CD44/NK1.1 profile of CD1d-tetramer + thymocytes was analyzed to test the potential role of miR-150 in iNKT cell maturation. We found that the frequency of mature NK1. (Fig. 3C) . The development and maturation of iNKT cells are also accompanied by the upregulation of several other cell surface receptors, such as CD122, CD69, and Ly-49 in addition to NK1.1, and the final steps of iNKT cell development also need the transcription factor T-bet and cytokine signaling initiated by IL-15 (8, 33, 34) . To further dissect the developmental impairment and the potential molecular mechanisms involved in iNKT cell development in miR-150KO mice, the expression levels of these molecules in iNKT cells were evaluated and compared between miR-150KO and WT control mice. As shown in Fig. 3D and 3E , the frequency of CD122-positive iNKT cells was significantly decreased in miR-150KO mice compared with WT control mice (p = 0.005), consistent with the defective iNKT cell maturation based on NK1.1 expression. Interestingly, the expressions of CD69, Ly49C, and T-bet in thymus iNKT cells were comparable between miR-150KO and WT control mice. Thus, miR-150KO mice have a partial defect in iNKT cell maturation at the late stage, suggesting that miR-150 regulates thymus iNKT cell development and maturation.
Immature iNKT cells also leave the thymus and are matured in the peripheral immune organs. Using NK1.1 as a peripheral iNKT cell maturation marker, peripheral iNKT cell maturation status was further evaluated in miR-150KO mice. As shown in Fig.  3F and 3G, iNKT cell maturation was slightly, but significantly interrupted in spleen and lymph nodes in miR-150KO mice (p = 0.021 and 0.046, respectively). Together, our data suggest that miR-150 also regulates peripheral iNKT cell maturation.
MiR-150 contributes to thymus iNKT cell survival during iNKT cell development
CD1d expressed in CD4 + CD8 + DP thymocyte controls iNKT selection and development, and mice lacking CD1d have severe defects in iNKT development (35) . To ascertain that the impaired iNKT cell development was not due to defective CD1d expression, thymocytes from miR-150KO and WT control mice were compared for CD1d expressions. As shown in Fig. 4A , CD1d expressions were found to be almost equivalent between miR-150KO and WT mice, ruling out the possibility of CD1d deficiency as a cause of the thymic iNKT developmental defects in miR-150KO mice.
To further dissect the mechanisms involved in thymus iNKT cell homeostasis, proliferation and apoptosis of thymus iNKT cells were evaluated in miR-150KO mice. To examine the former possibility, we injected miR-150KO and WT mice with BrdU and determined the rate of iNKT cell proliferation in the thymus. As shown in Fig. 4B and 4C , thymus iNKT cells from miR-150KO mice incorporated BrdU at a comparable rate compared with WT control mice. Thus, the disparity between the comparable proliferation observed and the overall decreased numbers of iNKT cells in the thymus suggested that increased cell death might be occurring in iNKT cells from miR-150KO mice. Therefore, fresh thymocytes from WT and miR-150KO mice were stained with the apoptotic marker annexin V to assess levels of cell apoptosis. As shown in Fig. 4D and 4E, miR-150KO mice showed a higher frequency of annexin V-positive iNKT cells than that of WT control mice (p = 0.031). Collectively, these data suggest that miR-150 regulates thymus iNKT cell survival, and may not be required for iNKT cell selection and proliferation.
Increased a-GalCer-mediated iNKT cell IFN-g production in miR-150KO mice
The prompt production of large amounts of cytokines in response to TCR signaling is a unique feature of iNKT cells, which is closely related to their potent immune regulatory functions (36) . To investigate the role of miR-150 in iNKT cell function, we injected mice with a-GalCer and evaluated the production of cytokines by iNKT cells with intracellular cytokine staining. As showed in Fig.  5A and 5B, 2 h after in vivo a-GalCer treatment, more spleen iNKT cells from miR-150KO mice produced IL-4 and IFN-g compared with that from WT control mice, especially for IFNg-producing NKT cells (p = 0.0004), suggesting the increased iNKT cell responsiveness to a-GalCer stimulation in the miR-150KO mice. However, CD69 expression in iNKT cells from miR-150 KO and WT mice was comparable. Interestingly, when spleen iNKT cells were stimulated in vitro with PMA and ionomycin, which bypass proximal TCR-mediated signaling events, comparable numbers of both IFN-g-and IL-4-producing iNKT cells were detected in miR-150KO and WT control mice (Fig. 5C,  5D ). These results suggest that miR-150 may regulate iNKT cell cytokine production, possibly through targeting the upstream TCR-mediated signaling molecular pathways.
MiR-150 deficiency affects iNKT cell maturation and function via a cell-autonomous mechanism
Accumulated studies suggest that iNKT cell development and function are regulated by both the bone marrow and microenvironments. To determine whether the altered iNKT cell development and cytokine secretion in miR-150KO mice are cell intrinsic or related to the defects in their environment, we used a mixed bone marrow transfer model, in which both WT and miR-150KO iNKT precursors develop in the same WT microenvironment. B6.SJL (CD45.1 + ) mice were lethally irradiated and reconstituted with a 1:1 mixture of bone marrow cells from the age-and sex-matched B6.SJL and miR-150KO mice (CD45.2 + ). iNKT cell development, maturation, and cytokine production capacity were analyzed after 8 wk postreconstitution. As shown in Fig. 6A , the bone marrow from miR-150KO mice reconstituted iNKT cells comparably to that from bone marrow of B6.SJL mice. However, significantly decreased mature CD44 + NK1.1 + and increased immature CD44 + NK1.1 2 iNKT cell frequency (p = 0.011) appeared in miR-150KO bone marrow-derived iNKT cells compared with that from B6.SJL mice (Fig. 6B, 6C ). In addition, miR-150KO bone marrow-derived iNKT cells showed significantly reduced CD122 expression compared with that from B6.SJL mice (p = 0.024) (Fig. 6D, 6E) . Furthermore, as shown in Fig. 6F , more IFN-g-and IL-4-producing iNKT cells were observed in miR-150KO bone marrow-derived iNKT cells compared with that from B6.SJL bone marrow after in vivo a-GalCer stimulation. Thus, the iNKT cell phenotypes in the bone marrow chimeras, including interrupted iNKT cell final stage maturation, reduced CD122 expression, and elevated a-GalCer-induced cytokine production, are consistent with the iNKT phenotypes identi- (30, 37, 38) . To investigate the potential involvement of c-Myb in miR-150-mediated iNKT cell regulation, we first evaluated c-Myb expression in thymus immature (stages 1 and 2) and mature (stage 3) iNKT cells by a TaqMan real-time RT-PCR. As shown in Fig. 7 , consistent with the observation in other lymphocytes, c-Myb is also highly expressed in immature iNKT cells and downregulated in mature iNKT cells. Thus, during iNKT cell development in thymus, the dynamic expression pattern of c-Myb is in mirror contrast with that of miR-150 (Figs. 1A, 7) , which may be required for iNKT cell maturation. Furthermore, c-Myb expression was significantly upregulated in both immature (stages 1 and 2) and mature (stage 3) iNKT cells from miR-150KO mice compared with that in WT mice (Fig. 7) . Thus, these data indicate that c-Myb may serve as one of the potential targets in miR-150-mediated late-stage iNKT cell development defect in the thymus.
Discussion
iNKT cells are a separate lineage of T lymphocyte that goes through a distinct developmental pathway controlled by a unique gene expression pattern (10) . In this study, we demonstrate an important role for miR-150 in directing the maturation and function of iNKT cells. Absence of miR-150 results in an impairment of iNKT cell maturation in both thymus and peripheral lymphoid organs and thymus iNKT cell homeostasis, but upregulates IFN-g cytokine production capacity. The maturation and functional changes of iNKT cells in miR-150KO mice are iNKT cell intrinsic. As miR-150 deletion resulted in upregulated c-Myb expression in both immature and mature thymus iNKT cells, c-Myb may be a major target through which miR-150 regulates NKT cell development, maturation, and function. During the submission, Lanier and colleagues (32) reported that miR-150 regulates the development of NK and NKT cells. In line with their findings, we also found the reduced frequency of NK cells in thymus and spleen from miR-150KO mice (data not shown), indicating that appropriate miR-150 expression is necessary for both NK and iNKT cell development. Furthermore, using a mixed bone marrow-transferring chimeras model, they also found that the frequency of thymic miR-150KO iNKT cells from WT: miR150KO chimeras was mildly decreased (1.5 6 0.2-fold compared with WT iNKT cells), and that loss of miR-150 in iNKT cells revealed a mild reduction in the population of thymic mature NK1.1 + iNKT cells. However, the reductions they detected were not statistically significant. One possible reason is that in their transferring experiments, four to five mice per group may not have enough power to detect a difference for this mild reduction, compared with the almost complete blocking of early iNKT cell development in the mice with miR-150 overexpression. Compared with iNKT cells in bone marrow-or thymus-specific total miRNA deletion mouse models (26) (27) (28) , miR-150 deletion alone is unlikely accountable for the profound interruption of iNKT cell development, maturation, and function identified in those mice. This may suggest the potential involvement of multiple miRNAs or groups of miRNAs in iNKT cell developmental and functional regulation, which is also supported by our recent miRNA expression profiles of iNKT cells (Q.H. Zheng, L. Zhou, and Q.S. Mi, unpublished observations).
INKT cells differentiate from DP conventional T cells and develop in thymus, with the final maturation step (NK1.1 expression) occurring in both the thymus and the periphery (1). Numerous transcription factors, cytokines, and signaling molecules have been identified as unique requirements for iNKT cell maturation once commitment to the NKT lineage has been confirmed. In particular, transcription factor T-bet is essential for final iNKT cell maturation (10, 34) . However, a difference in T-bet expression was not identified in the iNKT cells of miR-150KO mice compared with that of WT control mice, indicating that defective iNKT cell maturation in miR-150KO mice is not T-bet dependent. NF-kB, IL-15, IL-15Rb (CD122), and IL-2Rb also play an essential role in the maturation and overall population size of iNKT cells (39) (40) (41) . CD122 is upregulated between stages 2 and 3 of thymus iNKT development. Whether the immature iNKT cell phenotype in miR-150KO mice is induced by a failure to upregulate CD122 or a developmental blockage needs to be further identified. CD122 is involved in inducing expression of anti-apoptotic proteins Bcl-2 and Bcl-x L and is important for NKT cell homeostasis (42) . We have found that thymus iNKT cells from miR-150KO mice showed increased apoptosis compared with that from WT controls, which could result in a decreased iNKT cell ratio and number in miR-150KO mice.
Spleen and lymph node iNKT cells from miR-150KO mice showed a decrease in NK1.1 expression akin to the defective maturation of thymus iNKT. Consistent with previous studies showing that immature CD44 + NK1.1 2 iNKT cells preferably accumulate in the lymph nodes (43, 44) , lymph nodes of miR-150KO mice have increased iNKT cell frequency compared with that in WT control mice. As thymus and peripheral microenvironments differentially mediated development and maturation of iNKT cells, these results suggest that miR-150 is involved in both thymus and peripheral iNKT cell maturation. Given that iNKT cell maturation defects appear to be cell intrinsic, as demonstrated by our bone marrow chimera experiment (Fig. 6 ), the INKT cells rapidly secrete cytokines upon TCR stimulation, thus modulating acquired immune responses. In this study, we show that in addition to a role in iNKT cell maturation, miR-150 indeed negatively regulates iNKT cell production of IFN-g and, for a lesser extent, IL-4 upon TCR stimulation. It is well known that immature CD44 + NK1.1 2 iNKT cells produce more IL-4, whereas mature CD44 + NK1.1 + iNKT cells produce more IFN-g (8) . Considering that the lower ratio of mature CD44 + NK1.1 + iNKT cells present in the miR-150KO mice, the increased IFN-g production of iNKT cells in miR-150KO mice cannot be explained by the defective iNKT cell maturation. Other mechanisms must be involved in miR-150 regulating iNKT cell IFN-g production. Several transcription factors known to regulate cytokine gene transcription, such as T-bet, GATA-3, and NF-kB, have been implicated in iNKT cells (34, 39, 44, 45) . In addition, epigenetic regulation of IL-4 and IFN-g expression is reported to occur during iNKT cell development (46) . It was known that Notch signaling regulates IL-4 expression, whereas GM-CSF signaling controls IL-4 and IFN-g secretion without disturbing the transcription and translation of these two cytokines (47, 48) . Previous studies showed that c-Myb mRNA is induced upon B and T cell activation, whereas miR-150 expression was reduced upon B cell activation, suggesting the involvement of miR-150 and its target, c-Myb, in T and B cell activation and function (29, 49, 50) . In contrast with these results identified in T and B cells, however, iNKT cells stimulated with a-GalCer for 3 d showed increased miR-150 expression (Fig. 1C) , suggesting the potentially discrete mechanisms that exist in miR-150-mediated activation and functional regulation of iNKT cells versus T and B cells. The increased iNKT cytokine production upon a-GalCer stimulation instead of PMA/ionomycin stimulation in miR-150KO mice suggests that miR-150 controls IFN-g production through targeting proximal components of TCR signaling pathway. The detailed mechanisms of miR-150-mediated iNKT cell activation and cytokine production remain to be defined.
The transcription factor c-Myb is expressed in hematopoietic stem cells and progenitors of all hematopoietic lineages and is required for differentiation along individual hematopoietic cell lineages. In the thymus, DN and DP thymocyte subsets have the highest expression of c-Myb, and its expression decreases after positive selection (51, 52) . Conditional deletion of c-Myb at various stages of T cell development has suggested that c-Myb influences the DN to DP transition, the survival of DP thymocytes, and the differentiation of CD4 + thymocytes (51) . Alberola-Ila and colleagues (21) recently identified the central role of c-Myb in priming DP thymocytes to enter the iNKT lineage by simultaneously regulating CD1d expression, the t 1/2 of DP cells, and expression of SLAMF1, SLAMF6, and SAP. MiR-150 is specifically expressed in mature lymphcytes, but not their progenitors, which is opposite to the pattern of c-Myb expression. Combining loss-and gain-of-function gene-targeting approaches for miR-150, studies from Rajewsky and colleagues (30) showed miR-150 controls B cell differentiation through targeting c-Myb. Consistent with upregulated c-Myb expression in early iNKT cells from miR-150KO mice (Fig. 7) , we do not expect the abnormal iNKT cell selection and early development in miR-150KO mice. Most interestingly, Lanier and colleagues (32) recently reported that overexpression of miR-150 dramatically reduced iNKT cell number and blocked iNKT cell development in the early stage, which is related to downregulated expression of c-Myb, further indicating the importance of downregulation of miR-150 and upregulation of c-Myb for the early development of iNKT cells.
In contrast, constitutive expression of c-Myb has been reported to block erythrocyte maturation (53, 54) . A more recent study using a dose-and timing-controlled gene expression system showed overexpression of c-Myb; however, it prevented the terminal differentiation of erythrocytes and megakaryocytes (37) , indicating that appropriate levels of c-Myb protein are strictly defined at distinct development and differentiation steps of each hematopoietic cell lineage. In agreement with this notion, our study showed that miR-150 deletion, resulting in upregulated c-Myb expression level, mediated defective iNKT final maturation and changed function. This suggests the target role of c-Myb for miR-150 in iNKT cells and the necessity of miR-150-mediated c-Myb downregulation in the terminal maturation of iNKT cells. Therefore, the expression of the correct level at the appropriate time during differentiation seems to be important for c-Myb to regulate development and maturation of iNKT cells, in which miR-150 may be a critical player. However, we cannot exclude that other miR-150 potential target genes may also contribute to the iNKT cell phenotypes observed in miR-150 KO mice. For examples, miR-150 was demonstrated to target the transcription factor early growth response-2 and the purinergic P2X7 receptor, which has been suggested in controlling iNKT cell proliferation, apoptosis, and activation (55) (56) (57) (58) . Therefore, more credible evidence is needed to further confirm the target role of c-Myb in miR-150-mediated iNKT cell regulation.
In conclusion, we demonstrated a role for miR-150 in regulating the maturation and function of iNKT cells. Absence of miR-150 results in a moderate interruption of iNKT cell maturation in both thymus and peripheral lymphoid organs and thymus iNKT cell homeostasis, and upregulates their IFN-g production capacity. MiR-150-mediated iNKT maturation and function are cell intrinsic. Given the opposite expression levels of miR-150 and c-Myb in iNKT cells during their development and the critical role of miR-150 and c-Myb in iNKT cell development and maturation, it is likely that the dynamic expression of miR-150 is required for normal NKT cell development through controlling the proper levels of c-Myb expression.
